Charles River Laboratories | CRL - 销售毛利



金融业
股票价格
USD
资产
USD 7.53B
现金及等价物
USD 192.03M
销售成本
USD 655.29M
流动资产
USD 1.53B
流动负债
USD 1.13B
债务
USD 3.06B
EBIT
USD 119.89M
EBITDA
USD 272.95M
员工
18.6K
EPS每股收益
USD 3.02
股本和储备
USD 2.84B
销售毛利
USD 348.79M
债务利息支出
USD 30.34M
利息收入
USD -0.03
贷款资金
USD 2.62B
市值
USD 13.56B
净收入
USD -1.48M
营业费用
USD 2.84B
营业利润
USD 119.89M
普通股股本
USD 47.73M
PE价格收益
58.27
税前利润
USD -29.94M
销售收入
USD 1B
销售和管理费用
USD 228.9M
股票
USD 346.26M
贸易债权人
USD 140.98M
应收帐款人
USD 711.76M


销售毛利 更改 日
Agilent USD 990M 44M 2026-03
Align Technology USD 757.43M 20.84M 2026-06
Bio-Rad Laboratories USD 309.4M 35.8M 2026-03
Bruker USD 416M 36.2M 2026-06
Cardinal Health USD 2.5B 101M 2026-03
Charles River Laboratories USD 348.78M 69.47M 2026-06
Cigna USD 6.08B 50.37B 2026-03
Concord Medical Services Hldg CNY -37.42M 26.25M 2023-06
CVS Health USD 15.75B 125M 2026-06
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
Elevance Health USD 44.33B 32.65B 2026-06
Humana USD 4.82B 754M 2025-06
Illumina USD 770M 49M 2026-06
Incyte USD 1.57B 400.89M 2026-06
Intrexon USD -297K 167K 2024-06
IQVIA Holdings USD 1.44B 368M 2026-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Lonza CHF 1.29B 248M 2025-06
McKesson USD 3.68B 359M 2026-06
Merck EUR 3.07B 104M 2026-03
Mettler Toledo International USD 555.82M 119.62M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Quest Diagnostics USD 906M 33M 2026-03
Revvity USD 416.87M 29.21M 2026-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
United Therapeutics USD 683.8M 35.7M 2026-06
UnitedHealth USD 98.66B 73.25B 2026-06
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 490M 52M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03